Abstract
Twenty-two asymptomatic women with rising CA 125 levels after chemotherapy for ovarian cancer were entered into a trial of isotretinoin combined with calcitriol. Tumours were evaluated according to precise criteria based on serial CA 125 levels and by comparing regression slopes of CA 125 before and during therapy. There was no evidence based on CA 125 of any responses or significant change in tumour growth rate.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bower M., Colston K. W., Stein R. C., Hedley A., Gazet J. C., Ford H. T., Combes R. C. Topical calcipotriol treatment in advanced breast cancer. Lancet. 1991 Mar 23;337(8743):701–702. doi: 10.1016/0140-6736(91)90280-3. [DOI] [PubMed] [Google Scholar]
- Caliaro M. J., Marmouget C., Guichard S., Mazars P., Valette A., Moisand A., Bugat R., Jozan S. Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: relationship with induction of differentiation and retinoic acid receptor expression. Int J Cancer. 1994 Mar 1;56(5):743–748. doi: 10.1002/ijc.2910560522. [DOI] [PubMed] [Google Scholar]
- French L. E., Ramelet A. A., Saurat J. H. Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin. Lancet. 1994 Sep 3;344(8923):686–687. doi: 10.1016/s0140-6736(94)92122-9. [DOI] [PubMed] [Google Scholar]
- Lippman S. M., Kavanagh J. J., Paredes-Espinoza M., Delgadillo-Madrueño F., Paredes-Casillas P., Hong W. K., Holdener E., Krakoff I. H. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst. 1992 Feb 19;84(4):241–245. doi: 10.1093/jnci/84.4.241. [DOI] [PubMed] [Google Scholar]
- Majewski S., Skopinska M., Bollag W., Jablonska S. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet. 1994 Nov 26;344(8935):1510–1511. doi: 10.1016/s0140-6736(94)90330-1. [DOI] [PubMed] [Google Scholar]
- Raina V., Cunningham D., Gilchrist N., Soukop M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer. 1991 Mar;63(3):463–465. doi: 10.1038/bjc.1991.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rustin G. J., Nelstrop A. E., McClean P., Brady M. F., McGuire W. P., Hoskins W. J., Mitchell H., Lambert H. E. Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol. 1996 May;14(5):1545–1551. doi: 10.1200/JCO.1996.14.5.1545. [DOI] [PubMed] [Google Scholar]
- Rustin G. J., Nelstrop A. E., Tuxen M. K., Lambert H. E. Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study. Ann Oncol. 1996 Apr;7(4):361–364. doi: 10.1093/oxfordjournals.annonc.a010602. [DOI] [PubMed] [Google Scholar]
- Smith M. A., Parkinson D. R., Cheson B. D., Friedman M. A. Retinoids in cancer therapy. J Clin Oncol. 1992 May;10(5):839–864. doi: 10.1200/JCO.1992.10.5.839. [DOI] [PubMed] [Google Scholar]
- Thomsen K. Cutaneous T-cell lymphoma and calcitriol and isotretinoin treatment. Lancet. 1995 Jun 17;345(8964):1583–1583. doi: 10.1016/s0140-6736(95)91137-5. [DOI] [PubMed] [Google Scholar]
- van der Burg M. E., Lammes F. B., Verweij J. The role of CA 125 in the early diagnosis of progressive disease in ovarian cancer. Ann Oncol. 1990 Jul;1(4):301–302. doi: 10.1093/oxfordjournals.annonc.a057754. [DOI] [PubMed] [Google Scholar]
